Article
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.
The American journal of managed care - 1 Jan 2018
Lynch Julie A, Rothney Megan P, Salup Raoul R, Ercole Cesar E, Mathur Sharad C, Duchene David A, Basler Joseph W, Hernandez Javier, Liss Michael A, Porter Michael P, Wright Jonathan L, Risk Michael C, Garzotto Mark, Efimova Olga, Barrett Laurie, Berse Brygida, Kemeter Michael J, Febbo Phillip G, Dash Atreya
Abstract excerpt
BACKGROUND: Active surveillance (AS) has been widely implemented within Veterans Affairs' medical centers (VAMCs) as a standard of care for low-risk prostate cancer (PCa). Patient characteristics such as age, race, and Agent Orange (AO) exposure may influence advisability of AS in veterans. The 17-gene assay may improve risk stratification and management selection. OBJECTIVES: To compare management strategies for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.